A Comparison of 3 Vitamin D Dosing Regimens in Extremely Preterm Infants: A Randomized Controlled Trial

Abstract

Objective: To determine the optimal dose of vitamin D supplementation to achieve biochemical vitamin D sufficiency in extremely low gestational age newborns in a masked randomized controlled trial.

Study design: 100 infants 23 0/7-27 6/7 weeks gestation were randomized to vitamin D intakes of placebo (n = 36), 200 IU (n = 34), and 800 IU/d (n = 30) (approximating 200, 400, or 1000 IU/d, respectively, when vitamin D routinely included in parenteral or enteral nutrition is included). The primary outcomes were serum 25-hydroxy vitamin D concentrations on postnatal day 28 and the number of days alive and off respiratory support in the first 28 days.

Results: At birth, 67% of infants had 25-hydroxy vitamin D <20 ng/mL suggesting biochemical vitamin D deficiency. Vitamin D concentrations on day 28 were (median [25th-75th percentiles], ng/mL): placebo: 22 (13-47), 200 IU: 39 (26-57), 800 IU: 84.5 (52-99); P < .001. There were no differences in days alive and off respiratory support (median [25th-75th percentiles], days): placebo: 1 (0-11), 200 IU: 0 (0-8), and 800 IU: 0.5 (0-22); P = .63, or other respiratory outcomes among groups.

Conclusions: At birth, most extremely preterm infants have biochemical vitamin D deficiency. This biochemical deficiency is reduced on day 28 by supplementation with 200 IU/d and prevented by 800 IU/d. Larger trials are required to determine if resolution of biochemical vitamin D deficiency improves clinical outcomes.

Trial registration: ClinicalTrials.gov: NCT01600430.

Keywords: bronchopulmonary dysplasia; intraventricular hemorrhage; necrotizing enterocolitis; premature infant; randomized trial; retinopathy of prematurity; septicemia.

Conflict of interest statement

The author declares no conflicts of interest.

Copyright © 2016 Elsevier Inc. All rights reserved.

Figures

Figure 1. Revised template of the CONSORT diagram showing the flow of participants through each stage of a randomized trial

CONSORT diagram illustrates enrollment, allocation, follow-up, and analysis of the randomized controlled trial with two intervention groups (200 IU, 800 IU) and standard supplementation group (placebo) for vitamin D supplementation IU, international unit; NEC, necrotizing enterocolitis; SIP, spontaneous intestinal perforation; NPO, nil per os.

Figure 2

Box Plot illustrating serum 25(OH) vitamin D concentration at birth, day 14, and day 28 in three daily supplementation groups: placebo (total daily intake of approximately 200 IU/day found in formula or TPN), 200 IU/day (total daily intake of approximately 400 IU/day due to 200 IU supplement + 200 IU found in formula or TPN) and 800 IU/day (total daily intake of approximately 1000 IU/day due to 800 IU supplement + 200 IU found in formula or TPN). IU, international units; d, days.